Dose Finding Study for Depigoid Birch: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma

Clinical trial NCT01144429 · COMPLETED

Trial details

NCT number: NCT01144429
Sponsor: Leti Pharma GmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Allergic Rhinitis and/or Rhinoconjunctivitis +- Asthma Immunotherapy, Allergen

Start date: 2010-06-01
Primary completion: 2011-02-01
Enrollment: 344

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.